BEVERLY, Mass. - Axcelis Technologies, Inc. (NASDAQ:ACLS), known for its ion implantation technology crucial to semiconductor manufacturing, announced the election of Gregory Graves and Dr. Necip Sayiner to its Board of Directors.
The company's President and CEO, Russell Low, expressed confidence in the new appointments, citing the extensive experience both individuals bring in semiconductor technology, strategy, and business development. Low anticipates their expertise will significantly contribute to Axcelis's growth ambitions.
Graves brings a wealth of financial and strategic planning expertise to Axcelis, with a history as CFO of Entegris (NASDAQ:ENTG), Inc. from 2007 to 2023, and prior roles in investment banking and corporate development. His tenure at Entegris was preceded by strategic planning and business development positions, which he held from 2002 to 2007. Graves's academic credentials include degrees from the University of Alabama and an MBA from the University of Virginia. He also serves on the board of Skywater Technologies, Inc.
Dr. Sayiner adds a robust technical background to the board, with previous executive leadership at Renesas Electronics Corporation and as the president and CEO of Intersil Corporation. His industry experience is complemented by his current role on the board of Rambus (NASDAQ:RMBS), Inc. Dr. Sayiner's educational achievements include a doctorate in Electrical Engineering from the University of Pennsylvania and multiple degrees from Southern Illinois University and Bosphorus University in Turkey.
Axcelis, headquartered in Beverly, has been a part of the semiconductor industry for over four decades, focusing on the development and support of ion implantation systems, a key step in integrated circuit manufacturing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.